Factors associated with hospitalization of patients with angiotensin-converting enzyme
Management of angiotensin-converting enzyme
genotype and physical performance during US Army basic training.
An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme
1]R, is a metabolic product of angiotensin-converting enzyme
(ACE), we further determined whether or not UP-induced A[T.
Plasma level and gene polymorphism of angiotensin-converting enzyme
in relation to myocardial infarction.
It has been suggested that angiotensin-converting enzyme
(ACE) inhibitors and angiotensin type 1 receptor blockers (ARBs) have benefit beyond control of blood pressure.
The SARS-receptor molecule latched on to three proteins, but only one of these, angiotensin-converting enzyme
2 (ACE2), is typically found on the surface of mammalian cells.
The groups were given either 400 International Units of vitamin E a day or a placebo; or an angiotensin-converting enzyme
(ACE) inhibitor or a placebo.
Some examples in the cardiac area include angiotensin-converting enzyme
(ACE) inhibitors, which would be one class, and calcium channel-blockers would be another.
inhibitor therapy ought to be extended to a vastly expanded patient population.
inhibitors (ACEIs) are effective antihypertensive drugs, but use of ACEIs during the second and third trimesters of pregnancy has been associated with a pattern of defects known as ACEI fetopathy.